HOW TO TREAT HYPERTENSION IN BLACKS: REVIEW OF THE EVIDENCE

REFERENCES

• Hypertension Detection and FoRow-up Program Cooperative Group: Race, education, and preva[ence of hypertension. Am] Epidemiol 1977; 106: 351–361.
   PubMed Web of Science ®Google Scholar
• Toto RD, Hypertensive nephrosderosis in African Americans. Kidney Int 2003; 64: 2331–2341.
   PubMed Web of Science ®Google Scholar
• Cooper RS, Kaufman JS. Race and hypertension. Hypertension 1998; 32: 813–816.
   PubMed Web of Science ®Google Scholar
• Laag MJ, WheEton PK, RandaR BL, Neaton JD, Brancati FL, Stam-Fer J. End-stage renaE disease in African-American and white men: 16-year MRFIT findings. /AMA 1997; 277: 1293–1298.
   PubMed Web of Science ®Google Scholar
• Deedat Yk. Recommendations for hypertension in sub-SaharanAfrica. Cardiovasc J S Afr 2004; 15: 157–158.
   PubMedGoogle Scholar
• SiEwa K, WiEkinson D, Hansen C, et al Spectrum of Heart Dis-ease and Risk Factors in a !Mack Urban PopuEation in South Africa (The Heart of Soweto Study):A Cohort Study. Lancet 2008; 371: 915–922.
   PubMed Web of Science ®Google Scholar
• White HD, Dalby AJ. Heart disease in Soweto: facing a triple threat. Lancet 2008; 371:876–877.
   PubMed Web of Science ®Google Scholar
• Vorster HH. The emergence of cardiovascular disease during urbanisation of Africans. Public Health Nutr 2002; 5: 239–243.
   PubMed Web of Science ®Google Scholar
• Addo J, Smeeth L, Leon DA. Hypertension in Sub-Saharan Af-rica. A Systematic Review. Hypertension 2007; 50: 1012–1018.
   PubMed Web of Science ®Google Scholar
• Brown NJ. Hypertension and ethnic group. BM] 2006; 332:833–836.
   PubMed Web of Science ®Google Scholar
• Douglas JG, Wright JT Jr Blacks and Hypertension. Kalamazoo, Upjohn Company, 1992.
   Google Scholar
• Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27 (part 2): 481–490.
   PubMedGoogle Scholar
• Luft FC, MiRerJZ, Grim CE, et al. Salt sensitivity and resistance of blood pressure: Age and race as factors in physiological re-sponses. Hypertension 1991; 17: 1102–1108.
   Google Scholar
• Harshfield GA, Alpert BS, Pullam DA, et al. Sodium excretion and racial differences in ambulatory blood pressure patterns. Hypertension 1991; 18: 813–818.
   PubMed Web of Science ®Google Scholar
• Luft FC, Grim CE, Higgins JT, Weinberger MH. Differences in response to sodium administration in normotensive white and black subjects.J Lab Clin Med 1977; 90: 555–562.
   PubMed Web of Science ®Google Scholar
• Aviv A, Hollenberg NK, Weder AB. Sodium glomerulopathy: tub-uloglomeru Ear feedback and renal injury in African- Americans. Kidney Int 2004; 65:361–368.
   PubMed Web of Science ®Google Scholar
• Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H. Role of vasopressin in essential hypertension: Racial differences.] Hypertens 1997; 15: 545–550.
   PubMed Web of Science ®Google Scholar
• Juan Oliver. Vasopressin regulates the renin-angiotensin-al-dosterone system. Am J Physiol Renal Physiol 2008; 295: F100–F107.
   Web of Science ®Google Scholar
• Jeck N, Waldegger S, Lampert A. et al. Activating Mutation of the Renal Epithelial Chloride Channel CIC-Kb Predisposing to Hypertension. Hypertension 2004; 43: 1175–1181.
   PubMed Web of Science ®Google Scholar
• Falkner B. Differences in blacks and whites with essential hy-pertension: biochemistry and endocrine: state of the art lec-ture. Hypertension 1990; 15: 681–686.
   PubMed Web of Science ®Google Scholar
• Luft FC, Grim CE, Fineberg N, Weinberger MC. Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation 1979; 59:643–650.
   PubMed Web of Science ®Google Scholar
• Freis ED, Materson BJ, Flamenbaum W. Comparison of propra-nolol or hydrochlorothiazide alone for treatment of hyperten-sion. III. Evaluation of the renin-angiotensin system. Am] Med 1983; 74: 1029–1041.
   PubMed Web of Science ®Google Scholar
• Fray JCS: (pro) Renin processing and secretion in black essen-tial hypertension and other low-renin syndromes. In Fray JCS, Douglas JG (eds): Pathophysiology of Hypertension in Blacks. Oxford University Press for the American Physiological Society, 1993, pp 214–238.
   Google Scholar
• Laragh JH, Letcher RL, Pickering TG. Renin profiling for diagno-sis and treatment of hypertension. ]AMA 1979; 241:151–156.
   PubMed Web of Science ®Google Scholar
• Pratt JH, Jones JJ, MiRerJZ Wagner MA, Fineberg NS. Racial dif-ferences in aldosterone excretion and plasma aldosterone con-centrations in children. N EngIJ Med 1989; 321: 1152–1157.
   PubMed Web of Science ®Google Scholar
• Fisher ND, Gleason RE, Moore JT, Williams GH, Hollenberg NK. Regulations of aldosterone secretion in hypertensive blacks. Hypertension 1994; 23: 179–184.
   PubMed Web of Science ®Google Scholar
• MacGregor GA, Markandu ND, Roulston JE, Jones JC, Morton J J. Maintenance of blood pressure by the renin-angiotensin sys-tem in normal man. Nature 1981; 291: 329–331.
   PubMed Web of Science ®Google Scholar
• Li S, McAlpine DD, Liu J, Collins AJ. Differences between blacks and whites in the incidence of end-stage renal disease and as-sociated risk factors. Adv Ren Replace There 2004; 11: 5–13.
   PubMedGoogle Scholar
• Appel LJ, Wright JT Jr, Greene T, et al. Long-term Effects of Renin-Angiotensin System-Blocking Therapy and a Low Blood Pressure Goal on Progression of Hypertensive Chronic Kidney Disease in African Americans. Arch Intern Med 2008; 168: 832–839.
   PubMed Web of Science ®Google Scholar
• Parmer RJ, Stone RA, Cervenka J H. Renal hemodynamics in es-sential hypertensions. Racial differences in response to changes in dietary sodium. Hypertension 1994; 24: 752–757.
   PubMed Web of Science ®Google Scholar
• Klag MJ, Whelton PK, Coresh J, Grim CE, et al. The association of skin colour with blood pressure in US blacks with low socio-economic status. ]AMA 1991; 265: 599–602.
   PubMed Web of Science ®Google Scholar
• Sorel JE, Ragland DR, Seyme SL, et al. Educational status and blood pressure. The Second National Health and Nutrition Ex-amination Survey, 1976-1980, and The Hispanic Health and Nutrition Examination Survey, 1982-1984. Am J Epidemiol 1992; 175:1339–1348.
   Google Scholar
• Starfield B, Powe NR, Weiner JR, et al. Costs vs quality in dif-ferent types of primary care settings. ]AMA 1994; 272: 1903–1908.
   PubMed Web of Science ®Google Scholar
• Cooper R, Rotimi C, Ataman S et al. Hypertension prevalence in seven populations of African origin. Am J Public Health 1997; 87: 160–184.
   PubMed Web of Science ®Google Scholar
• Chiang BN, Perlman LV, Epstein FH. Overweight and hyperten-sion: a review. Circulation 1969; 39:403–421.
   PubMed Web of Science ®Google Scholar
• Hypertension Detection and Follow-up Program Cooperative Group: Five year findings of the hypertension detection and follow-up program. II. Mortality by race, sex and age. JAMA 1979; 242:2572–2577.
   PubMed Web of Science ®Google Scholar
• Hebert LA, Agarwal G, Ladson-Wofford SE, et al. Nocturnal blood pressure in treated hypertensive African-Americans compared to treated hypertensive European Americans. J Am Soc Nephrol 1996; 7: 2130–2134.
   PubMed Web of Science ®Google Scholar
• Curry CL. Coronary artery disease in African-Americans. Circu-lation 1991; 83: 1474–1475.
   PubMed Web of Science ®Google Scholar
• Taylor JO, Borhani NO, Entwisle G, Farber N, Hawkins CM. (Hy-pertension detection and follow-up program). Summary of the baseline characteristics of the hypertensive participants. Hy-pertension 1983; 5 (Suppl IV): IV44-1V50.
   PubMedGoogle Scholar
• Akinboboye O, Idris O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans.] Hum Hypertens 2003; 17: 381–387.
   PubMed Web of Science ®Google Scholar
• Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: the Interheart Africa Study. Cir-culation 2005; 112: 3554–3561.
   PubMed Web of Science ®Google Scholar
• Rosamond W, Regal K, Friday G, et al. Heart Disease and Stroke Statistics-2007 Update:A Report From the American Heart As-sociation Statistics Committee and Stroke Statistics Subcom-mittee. Circulation 2007; 115: e69–e171.
   Web of Science ®Google Scholar
• Caplan LR. Strokes in African-Americans. Circulation 1991; 83: 1469–1471.
   PubMed Web of Science ®Google Scholar
• Connor MD, Thorogood M, Casserly B, et al. Prevalence of stroke survivors in rural South Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke 2004; 35:627–632.
   PubMed Web of Science ®Google Scholar
• Cruickshank JK, Mbanya JC, Wks R et al. Hypertension in four African-origin populations: current 'rule of halves', quality of blood pressure control and attributable risk of cardiovascular disease.JHypertens 2001;19: 41–46.
   PubMed Web of Science ®Google Scholar
• Okosun I, Cooper RS, Muna W. Epidemiology of stroke in African populations outside of the United States. In: Gillum R, Gorelide P, Cooper E, eds. Stroke in Blacks. Basel: Karger; 1999: 70-82.
   Google Scholar
• Opie LH, Seedat YK. Hypertension in Sub-Saharan African Pop-ulations. Circulation 2005; 112: 3562–3568.
   PubMed Web of Science ®Google Scholar
• Broderick JP, Brott T, Tomsick T, Huster G, Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med 1992; 326: 733–736.
   PubMed Web of Science ®Google Scholar
• Klatsky AL, Armstrong MA, Friedman GD. Racial differences in cere-brovascular disease hospitalizations. Stroke 1991; 22: 299–304.
   PubMed Web of Science ®Google Scholar
• Powers DR, Wallin JD. End-stage renal disease in specifi c ethnic and racial groups: risk factors and benefi ts of antihypertensive therapy. Arch Intern Med 1998; 158: 753–800.
   PubMedGoogle Scholar
• Norris KC, Hornhill-Joynes M, Robinson C, et al. Cocaine use, hypertension, and end-stage renal disease. Am J Kidney Dis 2001; 38: 523–528.
   PubMed Web of Science ®Google Scholar
• Anderson S, Brenner BM. The critical role of nephron mass and of intraglomerular pressure for initiation and progression of experimental hypertensive-renal disorders (chapter 73), in Hypertension: Pathophysiology, diagnosis & Management, edited by Laragh JH, Brenner BM, New-York, 1990: 1163–1178.
   Google Scholar
• Li S, Chen SC, Shlipak M, et al. and Kidney Early Evaluation Program Investigators Chronic Disease Research Group. Low birth weight is associated with chronic kidney disease only in men. Kidney Int 2008; 73(5): 637–642.
   PubMed Web of Science ®Google Scholar
• Krzesinski J-M, Cohen E.P. Hypertension and the Kidney. Acta Clinica Belgica 2007; 62(1),5–14.
   PubMed Web of Science ®Google Scholar
• Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension: a scientifi c statement from the American Heart Association. Hypertension 2006; 47: 296–308
   PubMed Web of Science ®Google Scholar
• Lemogoum D, Seedat YK, Mabadeje AF, et al. International Forum for Hypertension Control and Prevention in Africa. Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa. J Hypertens 2003;21:1993–2000.
   Google Scholar
• Kokkinos PF, Narayan P, Colleran JA, et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 1995; 333:1462–1467.
   PubMed Web of Science ®Google Scholar
• Swift PA, Markandu ND, Sagnella GA, et al. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trials. Hypertension 2005; 46: 308–312.
   PubMed Web of Science ®Google Scholar
• Seedat JK, Varying responses to hypotensive agents in different racial groups: black versus white differences. J Hypertens 1989;
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560–2572.
   PubMed Web of Science ®Google Scholar
• Materson BJ, Reda DJ, Cushman WC, et al. For the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. (correction: N Engl J Med 1994; 330: 1689). N Engl J Med 1993; 328: 914–921.
   PubMed Web of Science ®Google Scholar
• The ALLHAT Offi cers and Coordinators, for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–2997.
   PubMed Web of Science ®Google Scholar
• ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treat-ment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000; 283: 1967–2015.
   PubMed Web of Science ®Google Scholar
• Wright JT Jr, Dunn JK, Cutler JA et al. For the ALLHAT Collabora-tive Research Group. Outcomes in hypertensive black and non black patients treated with chlorthalidone, amlodipine, and lisinopril.JAMA 2005; 293: 1595–1608.
   PubMed Web of Science ®Google Scholar
• Pratt JH, Ambrosius WT, Agarwal R, Eckert GJ, Newman S. Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension 2002; 40: 903–908.
   PubMed Web of Science ®Google Scholar
• Saha C, Eckert GJ, Ambrosius WT, et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension 2005; 46:481–487.
   PubMed Web of Science ®Google Scholar
• Flack JM, Oparil S, Pratt JH, et al. Efficacy and tolerability of eplerenone and losartan in hypertensive black patients and white patients. J Am Coll Cardiol 2003; 41: 1148–1155.
   PubMed Web of Science ®Google Scholar
• Sareli P, Radevski IV, Valtchanova ZP, et al. Efficacy of differ-ent drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arch Intern Med 2001; 161: 965–971.
   PubMed Web of Science ®Google Scholar
• Saunders E, Weir MR, Kong BW et al. A comparison of the ef-ficacy and safety of a beta-Mocker, a calcium channel Mocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990; 150:1707–1713.
   PubMed Web of Science ®Google Scholar
• Dallas HW, Reed JW, Flack J M, Yunis C, Preisser J and the ISHIB Investigators Group. Comparison of the efficacy of dihydro-pyridine calcium channel Mockers in African American patients with hypertension. Arch Intern Med 1998; 158: 2029–2034.
   PubMed Web of Science ®Google Scholar
• Weir MR, Ferdinand KC, Flack JM, et al. For the ADVANCE Inves-tigators. A non inferiority comparison of valsartan/hydrochlo-rothiazide combinations versus amlodipine in black hyperten-sives. Hypertension 2005; 46: 508–513.
   PubMed Web of Science ®Google Scholar
• Maciejewski S, Mohiuddin SM, Packard KA, et al. Randomized, double-blind, crossover comparison of amlodipine and valsar-tan in African-Americans with hypertension using 24-hour am-bulatory blood pressure monitoring. Pharmacotherapy 2006 ; 26:889–895.
   PubMed Web of Science ®Google Scholar
• Wright JT Jr, Dunn JK, Cutler JA, et al. For the ALLHAT Collab-orative Research Group. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine and lisinopril.JAMA 2005, 293: 1595–1507.
   PubMed Web of Science ®Google Scholar
• Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996; 60(1): 8–13.
   PubMed Web of Science ®Google Scholar
• Elliott WJ. Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects. Clin Pharmacol Ther 1996; 60(5): 582–588.
   PubMed Web of Science ®Google Scholar
• Middlemost Si, Tager RT, David JD, Sareli P. Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hyperten-sion in black patients. Am J Cardiol 1994; 73:1092–1097.
   PubMed Web of Science ®Google Scholar
• Weir MR, Gray JM, Paster R, Saunders E. For the Trandolapril Multicenter Study Group. Differing mechanisms of action of angiotensin- converting enzyme inhibition in black and white hypertensive patients. Hypertension 1995; 26: 124–130.
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Anti-hypertensive Agents. Comparison of propranolol and hydrochlorothiazide for initial treatment of hypertension:I. Results of short-term titration with emphasis on racial differences in response. /AMA 1982; 248: 1996–2003.
   PubMed Web of Science ®Google Scholar
• Bosman AR, Goldberg B, et al. South African multicenter study of metoprolol and propranolol in essential hypertension. S Afr Med 1977; 51: 57–61.
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Anti-hypertensive Agents. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hyper-tension. Am J Cardiol 1983; 52: 1230–1237.
   PubMed Web of Science ®Google Scholar
• Saunders E, Smith WB, DeSalvo KB, Sullivan WA. The efficacy and tolerability of nebivolol in hypertensive African-American patients.] Clin Hypertens 2007; 9:866–875.
   PubMedGoogle Scholar
• Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high risk and low-risk patients after myocar-dial Infarction. N Eng1J Med 1998; 339:489–497.
   PubMed Web of Science ®Google Scholar
• Dargie HI Effect of carvedilol on outcome after myocardial in-farction in patients with left ventricular dysfunction: the CAP-RICORN randomized trial. Lancet 2001; 357: 1385–1390.
   PubMed Web of Science ®Google Scholar
• Agodoa LY, Appel L, Bakris GL, et al. African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis : a randomized controlled trial. JAMA 2001; 285: 2719–2728.
   PubMed Web of Science ®Google Scholar
• Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African-Americans: consensus statement of the Hypertension in African-Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003; 163: 525–541.
   PubMed Web of Science ®Google Scholar
• Kidney Disease Outcomes Quality Initiative (K/DOQI). K/ DOQI Clinical Practice Guidelines on Hypertension and anti-hypertensive agents in chronic Kidney disease. Am J Kidney Dis 2004; 43 (5) (suppl 1): S1–S29.
   Google Scholar
• European Society for Hypertension-European Society of Car-diology Guidelines Committee. 2007 European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial hypertension.J Hypertens 2007; 25:1105–1187.
   Google Scholar
• Veterans Administration Cooperative Study Group on Antihy-pertensive. Agents. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. Br J Clin Pharmaco11982; 14 (suppl 2): 975-101S.
   Google Scholar
• Joint National Committee on Prevention, Detection, Evalua-tion, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evalu-ation, and Treatment of High Blood Pressure (i NC VI). Arch In-tern Med 1997; 157: 2413–2466.
   PubMed Web of Science ®Google Scholar
• Guidelines Subcommittee of the World Health Organization-International Society of Hypertension (WHO-ISH) Mild Hyper-tension Liaison Committee. 1999 World Health Organization-International Society of Hypertension guidelines for the man-agement of hypertension. ].Hypertens 1999; 17: 151–183.
   PubMed Web of Science ®Google Scholar